Fred Aslan, Chief Executive Officer at Artiva Biotherapeutics, Inc. (ARTV), sold 27,116 shares at $9.01 ($244K) on 2026-05-19, disclosed to the SEC on 2026-05-19.
Open-market sale of $244k ARTV by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| ARTV | SELL | 2026-09-09 | $256K | — | Filing → |
| ARTV | SELL | 2026-09-04 | $690K | — | Filing → |
| ARTV | SELL | 2025-12-15 | $19K | — | Filing → |